Current and Emerging Diagnostic Approaches for Tuberculosis in People Living with HIV: Challenges and Future Perspectives [PDF]
Tuberculosis (TB) remains a leading cause of morbidity and mortality among people living with human immunodeficiency virus (HIV), in whom immunosuppression often results in atypical clinical manifestations, paucibacillary disease, extrapulmonary ...
Guillermo Eduardo Cuéllar-Nevárez +5 more
doaj +2 more sources
Toward a National Tuberculosis Lateral-Flow Urine Lipoarabinomannan (LF-LAM) External Quality Assessment Program in Thailand: Feasibility Demonstration Through Panel Development, Validation, and Proficiency Testing, March 2025–April 2026 [PDF]
Background: The World Health Organization and the Thailand National HIV Treatment Guidelines recommend the use of lateral flow urine lipoarabinomannan (LF-LAM) testing for tuberculosis (TB) detection in people living with HIV (PLHIV) with advanced HIV ...
Supaporn Suparak +17 more
doaj +2 more sources
A novel non-invasive diagnostic approach based on urine and blood: a cross-sectional study combining lipoarabinomannan antigen and interferon-gamma release assay for active tuberculosis [PDF]
PurposeTo evaluate the diagnostic value of a combined strategy using the urine lipoarabinomannan (LAM) antigen assay and interferon-gamma release assay (IGRA) for active tuberculosis (TB), and to explore its potential as a non-invasive, sputum ...
Long Cai +6 more
doaj +2 more sources
Rapid urinary lipoarabinomannan test with laboratory-level sensitivity for tuberculosis detection: a performance evaluation [PDF]
Developing rapid, non-sputum-based tests is a global priority to improve the diagnosis and timely treatment of tuberculosis (TB). In this study, we evaluated the detection limit, precision, stability, and lot-to-lot variation of a next-generation rapid ...
Qisheng Jiang +11 more
doaj +2 more sources
The utility of urine lipoarabinomannan as a tuberculosis treatment monitoring tool in people living with HIV [PDF]
Objective This pilot study aimed to evaluate whether urine lipoarabinomannan (LAM) testing can be used to monitor tuberculosis treatment response in people living with HIV. Results Seventy-five participants were enrolled, of whom 51 (68%) were women, and
Brian Otaalo +10 more
doaj +2 more sources
Lipoarabinomannan is a major immunomodulatory lipoglycan found in the cell envelope of Mycobacterium tuberculosis and related human pathogens. It reproduces several salient properties of M.
Martine Gilleron +2 more
exaly +3 more sources
High performance of point-of-care rapid tests for advanced HIV disease diagnosis by lay providers in Malawi: Results from a prospective diagnostic accuracy study supporting decentralized advanced HIV disease screening. [PDF]
CD4 testing is essential for identifying people with advanced HIV(AHD) disease and enabling delivery of the recommended diagnostic package including serum cryptococcal antigen (CrAG)and urine lipoarabinomannan(LAM) testing and prophylaxis.
Agness Thawani +19 more
doaj +2 more sources
Lipoarabinomannan as a Point-of-Care Assay for Diagnosis of Tuberculosis: How Far Are We to Use It?
Tuberculosis (TB) is still a severe public health problem; the current diagnostic tests have limitations that delay treatment onset. Lipoarabinomannan (LAM) is a glycolipid that is a component of the cell wall of the bacillus Mycobacterium tuberculosis ...
Julio Flores +3 more
doaj +1 more source
Towards Accurate Point-of-Care Tests for Tuberculosis in Children
In childhood tuberculosis (TB), with an estimated 69% of missed cases in children under 5 years of age, the case detection gap is larger than in other age groups, mainly due to its paucibacillary nature and children’s difficulties in delivering sputum ...
Nina Vaezipour +7 more
doaj +1 more source
Background: Tuberculosis (TB) is a major cause of mortality in persons living with HIV (PLWH). Sputum-based diagnosis of TB in patients with low CD4 counts is hampered by paucibacillary disease and consequent sputum scarcity or negative sputum results ...
Lior Chernick +2 more
doaj +1 more source

